|
|
Volumn 12, Issue 10, 2013, Pages 1473-1474
|
|
Arsenic reverses glioblastoma resistance to mTOR-targeted therapies
a
b
c
c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 (4 AMINO 1 ISOPROPYL 1H PYRAZOLO[3,4 D]PYRIMIDIN 3 YL) 1H INDOL 5 OL;
ARSENIC TRIOXIDE;
ERLOTINIB;
MAMMALIAN TARGET OF RAPAMYCIN;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
PROMYELOCYTIC LEUKEMIA PROTEIN;
RAPAMYCIN;
SMALL INTERFERING RNA;
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MTOR PROTEIN, HUMAN;
ORGANOARSENIC DERIVATIVE;
OXIDE;
QUINAZOLINE DERIVATIVE;
TARGET OF RAPAMYCIN KINASE;
CANCER CELL;
CANCER CHEMOTHERAPY;
EDITORIAL;
GLIOBLASTOMA;
HUMAN;
HUMAN CELL;
IMMUNOHISTOCHEMISTRY;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
SIGNAL TRANSDUCTION;
SUMOYLATION;
UBIQUITINATION;
UPREGULATION;
ANTAGONISTS AND INHIBITORS;
BRAIN NEOPLASMS;
DRUG RESISTANCE;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
METABOLISM;
ANTINEOPLASTIC AGENTS;
ARSENICALS;
BRAIN NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
GLIOBLASTOMA;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
OXIDES;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
SIGNAL TRANSDUCTION;
SIROLIMUS;
TOR SERINE-THREONINE KINASES;
|
|
EID: 84877992657
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.24747 Document Type: Editorial |
|
Times cited : (7)
|
|
References (9)
|
